Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Efficacy and Safety Study of FID 123320 Ophthalmic Solution for the Reduction of Ocular Redness in Pediatric and Adult Populations

NCT06538662 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT06538662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Efficacy and Safety Study of FID 123320 Ophthalmic Solution for the Reduction of Ocular Redness in Pediatric and Adult Populations
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
October 7, 2024
Completion date
April 3, 2025
Enrollment
283 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

eye irritation, ocular redness